{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T18:22:00Z","timestamp":1771870920753,"version":"3.50.1"},"reference-count":26,"publisher":"Impact Journals, LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncoscience"],"published-print":{"date-parts":[[2025,12,30]]},"DOI":"10.18632\/oncoscience.644","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T17:52:23Z","timestamp":1771869143000},"page":"35-43","source":"Crossref","is-referenced-by-count":0,"title":["Reduced immunogenicity of MYC amplified, metastatic prostate cancer"],"prefix":"10.18632","volume":"13","author":[{"given":"Sunny","family":"Kahlon","sequence":"first","affiliation":[{"name":"Department of Surgery, The University of Tennessee Health Science Center, Memphis, TN 38163, USA"},{"name":"Center for Cancer Research, College of Medicine, The University of Tennessee Health Science Center, Memphis, TN 38163, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vayda R.","family":"Barker","sequence":"additional","affiliation":[{"name":"Department of Surgery, The University of Tennessee Health Science Center, Memphis, TN 38163, USA"},{"name":"Center for Cancer Research, College of Medicine, The University of Tennessee Health Science Center, Memphis, TN 38163, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mallika","family":"Varkhedi","sequence":"additional","affiliation":[{"name":"Department of Surgery, The University of Tennessee Health Science Center, Memphis, TN 38163, USA"},{"name":"Center for Cancer Research, College of Medicine, The University of Tennessee Health Science Center, Memphis, TN 38163, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex Y.","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Surgery, The University of Tennessee Health Science Center, Memphis, TN 38163, USA"},{"name":"Center for Cancer Research, College of Medicine, The University of Tennessee Health Science Center, Memphis, TN 38163, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taha I.","family":"Huda","sequence":"additional","affiliation":[{"name":"Department of Surgery, The University of Tennessee Health Science Center, Memphis, TN 38163, USA"},{"name":"Center for Cancer Research, College of Medicine, The University of Tennessee Health Science Center, Memphis, TN 38163, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Blanck","sequence":"additional","affiliation":[{"name":"Department of Surgery, The University of Tennessee Health Science Center, Memphis, TN 38163, USA"},{"name":"Center for Cancer Research, College of Medicine, The University of Tennessee Health Science Center, Memphis, TN 38163, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Rawla P. Epidemiology of Prostate Cancer. World J Oncol. 2019; 10:63\u201389. https:\/\/doi.org\/10.14740\/wjon1191. PMID:31068988","DOI":"10.14740\/wjon1191"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Belkahla S, Nahvi I, Biswas S, Nahvi I, Ben Amor N. Advances and development of prostate cancer, treatment, and strategies: A systemic review. Front Cell Dev Biol. 2022; 10:991330. https:\/\/doi.org\/10.3389\/fcell.2022.991330. PMID:36158198","DOI":"10.3389\/fcell.2022.991330"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Siegel DA, O\u2019Neil ME, Richards TB, Dowling NF, Weir HK. Prostate Cancer Incidence and Survival, by Stage and Race\/Ethnicity - United States, 2001-2017. MMWR Morb Mortal Wkly Rep. 2020; 69:1473\u201380. https:\/\/doi.org\/10.15585\/mmwr.mm6941a1. PMID:33056955","DOI":"10.15585\/mmwr.mm6941a1"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Qiu X, Boufaied N, Hallal T, Feit A, de Polo A, Luoma AM, Alahmadi W, Larocque J, Zadra G, Xie Y, Gu S, Tang Q, Zhang Y, et al. MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targets. Nat Commun. 2022; 13:2559. https:\/\/doi.org\/10.1038\/s41467-022-30257-z. PMID:35562350","DOI":"10.1038\/s41467-022-30257-z"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Adamo P, Ladomery MR. The oncogene ERG: a key factor in prostate cancer. Oncogene. 2016; 35:403\u201314. https:\/\/doi.org\/10.1038\/onc.2015.109. PMID:25915839","DOI":"10.1038\/onc.2015.109"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Wang G, Zhao D, Spring DJ, DePinho RA. Genetics and biology of prostate cancer. Genes Dev. 2018; 32:1105\u201340. https:\/\/doi.org\/10.1101\/gad.315739.118. PMID:30181359","DOI":"10.1101\/gad.315739.118"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Kgatle MM, Boshomane TMG, Lawal IO, Mokoala KMG, Mokgoro NP, Lourens N, Kairemo K, Zeevaart JR, Vorster M, Sathekge MM. Immune Checkpoints, Inhibitors and Radionuclides in Prostate Cancer: Promising Combinatorial Therapy Approach. Int J Mol Sci. 2021; 22:4109. https:\/\/doi.org\/10.3390\/ijms22084109. PMID:33921181","DOI":"10.3390\/ijms22084109"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Layer JP, Kronm\u00fcller MT, Quast T, van den Boorn-Konijnenberg D, Effern M, Hinze D, Althoff K, Schramm A, Westermann F, Peifer M, Hartmann G, T\u00fcting T, Kolanus W, et al. Amplification of N-Myc is associated with a T-cell-poor microenvironment in metastatic neuroblastoma restraining interferon pathway activity and chemokine expression. Oncoimmunology. 2017; 6:e1320626. https:\/\/doi.org\/10.1080\/2162402X.2017.1320626. PMID:28680756","DOI":"10.1080\/2162402X.2017.1320626"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Zhang P, Wu X, Basu M, Dong C, Zheng P, Liu Y, Sandler AD. MYCN Amplification Is Associated with Repressed Cellular Immunity in Neuroblastoma: An In Silico Immunological Analysis of TARGET Database. Front Immunol. 2017; 8:1473. https:\/\/doi.org\/10.3389\/fimmu.2017.01473. PMID:29163537","DOI":"10.3389\/fimmu.2017.01473"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Dabkowski TR, Varkhedi M, Song JJ, Gozlan EC, Blanck G. Neuroblastoma and Glioblastoma Cases With Amplified Oncogenes Have Reduced Numbers of Tumor-Resident Adaptive Immune Receptor Recombinations. JCO Precis Oncol. 2023; 7:e2300057. https:\/\/doi.org\/10.1200\/PO.23.00057. PMID:38085056","DOI":"10.1200\/PO.23.00057"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Mauro JA, Yavorski JM, Blanck G. Stratifying melanoma and breast cancer TCGA datasets on the basis of the CNV of transcription factor binding sites common to proliferation-and apoptosis-effector genes. Gene. 2017; 614:37\u201348. https:\/\/doi.org\/10.1016\/j.gene.2017.02.026. PMID:28257835","DOI":"10.1016\/j.gene.2017.02.026"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Varkhedi M, Barker VR, Eakins RA, Blanck G. CNV assessments associated with outcome distinctions for adult and pediatric cancers: Loss of BRCA1 in neuroblastoma associates with a lower survival probability. Gene. 2022; 836:146673. https:\/\/doi.org\/10.1016\/j.gene.2022.146673. PMID:35714795","DOI":"10.1016\/j.gene.2022.146673"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Gill TR, Samy MD, Butler SN, Mauro JA, Sexton WJ, Blanck G. Detection of Productively Rearranged TcR-\u03b1 V-J Sequences in TCGA Exome Files: Implications for Tumor Immunoscoring and Recovery of Antitumor T-cells. Cancer Inform. 2016; 15:23\u201328. https:\/\/doi.org\/10.4137\/CIN.S35784. PMID:26966347","DOI":"10.4137\/CIN.S35784"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Tong WL, Tu YN, Samy MD, Sexton WJ, Blanck G. Identification of immunoglobulin V(D)J recombinations in solid tumor specimen exome files: Evidence for high level B-cell infiltrates in breast cancer. Hum Vaccin Immunother. 2017; 13:501\u20136. https:\/\/doi.org\/10.1080\/21645515.2016.1246095. PMID:28085544","DOI":"10.1080\/21645515.2016.1246095"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Chobrutskiy BI, Zaman S, Tong WL, Diviney A, Blanck G. Recovery of T-cell receptor V(D)J recombination reads from lower grade glioma exome files correlates with reduced survival and advanced cancer grade. J Neurooncol. 2018; 140:697\u2013704. https:\/\/doi.org\/10.1007\/s11060-01803001-1. PMID:30382482","DOI":"10.1007\/s11060-018-03001-1"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Dhanasekaran R, Deutzmann A, Mahauad-Fernandez WD, Hansen AS, Gouw AM, Felsher DW. The MYC oncogene - the grand orchestrator of cancer growth and immune evasion. Nat Rev Clin Oncol. 2022; 19:23\u201336. https:\/\/doi.org\/10.1038\/s41571-021-00549-2. PMID:34508258","DOI":"10.1038\/s41571-021-00549-2"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Dhanasekaran R, Hansen AS, Park J, Lemaitre L, Lai I, Adeniji N, Kuruvilla S, Suresh A, Zhang J, Swamy V, Felsher DW. MYC Overexpression Drives Immune Evasion in Hepatocellular Carcinoma That Is Reversible through Restoration of Proinflammatory Macrophages. Cancer Res. 2023; 83:626\u201340. https:\/\/doi.org\/10.1158\/0008-5472.CAN22-0232. PMID:36525476","DOI":"10.1158\/0008-5472.CAN-22-0232"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Ogino S, Galon J, Fuchs CS, Dranoff G. Cancer immunology--analysis of host and tumor factors for personalized medicine. Nat Rev Clin Oncol. 2011; 8:711\u201319. https:\/\/doi.org\/10.1038\/nrclinonc.2011.122. PMID:21826083","DOI":"10.1038\/nrclinonc.2011.122"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Paniagua-Herranz L, Doger B, D\u00edaz-Tejeiro C, Sanvicente A, Nieto-Jim\u00e9nez C, Moreno V, P\u00e9rez Segura P, Gyorffy B, Calvo E, Ocana A. Genomic Mapping of Epidermal Growth Factor Receptor and Mesenchymal-Epithelial TransitionUp-Regulated Tumors Identifies Novel Therapeutic Opportunities. Cancers (Basel). 2023; 15:3250. https:\/\/doi.org\/10.3390\/cancers15123250. PMID:37370859","DOI":"10.3390\/cancers15123250"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Bryant G, Wang L, Mulholland DJ. Overcoming Oncogenic Mediated Tumor Immunity in Prostate Cancer. Int J Mol Sci. 2017; 18:1542. https:\/\/doi.org\/10.3390\/ijms18071542. PMID:28714919","DOI":"10.3390\/ijms18071542"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Zhu Y, Duong L, Lu X, Lu X. Cancer-cell-intrinsic mechanisms shaping the immunosuppressive landscape of prostate cancer. Asian J Androl. 2023; 25:171\u201378. https:\/\/doi.org\/10.4103\/aja202283. PMID:36367020","DOI":"10.4103\/aja202283"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Mauro JA, Butler SN, Ramsamooj M, Blanck G. Copy number loss or silencing of apoptosis-effector genes in cancer. Gene. 2015; 554:50\u201357. https:\/\/doi.org\/10.1016\/j.gene.2014.10.021. PMID:25307873","DOI":"10.1016\/j.gene.2014.10.021"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R, and 1000 Genome Project Data Processing Subgroup. The Sequence Alignment\/Map format and SAMtools. Bioinformatics. 2009; 25:2078\u201379. https:\/\/doi.org\/10.1093\/bioinformatics\/btp352. PMID:19505943","DOI":"10.1093\/bioinformatics\/btp352"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009; 25:1754\u201360. https:\/\/doi.org\/10.1093\/bioinformatics\/btp324. PMID:19451168","DOI":"10.1093\/bioinformatics\/btp324"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, Cerami E, Sander C, Schultz N. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013; 6:pl1. https:\/\/doi.org\/10.1126\/scisignal.2004088. PMID:23550210","DOI":"10.1126\/scisignal.2004088"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, Antipin Y, Reva B, Goldberg AP, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012; 2:401\u2013404. https:\/\/doi.org\/10.1158\/2159-8290.CD-12-0095. PMID:22588877","DOI":"10.1158\/2159-8290.CD-12-0095"}],"container-title":["Oncoscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncoscience.us\/lookup\/doi\/10.18632\/oncoscience.644","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T17:52:26Z","timestamp":1771869146000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncoscience.us\/lookup\/doi\/10.18632\/oncoscience.644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,30]]},"references-count":26,"alternative-id":["644"],"URL":"https:\/\/doi.org\/10.18632\/oncoscience.644","relation":{},"ISSN":["2331-4737"],"issn-type":[{"value":"2331-4737","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,30]]}}}